The Mapk-activated protein Kinase 2 (MK2) inhibitor CMPD1 is a novel microtubule targeting agent for Glioblastoma Therapy
2015
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI